← Dolby Laboratories, Inc. DLB
Market Price
$62.36
Market Cap
$5.90B
P/E Ratio
23.80
Revenue (FY 2025)
↑5.9% YoY
$1.35B
3-Yr CAGR: 2.5%
Net Income
↓-2.6% YoY
$255.02M
Net Margin: 18.9%
Free Cash Flow
↑46.6% YoY
$435.85M
FCF Yield: 7.39%
EPS (Diluted)
↓-2.6% YoY
$2.62
Basic: $2.66
Return on Equity
Efficiency
9.7%
ROA: 491.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (DLB)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,025.7M | — | $916.8M | $185.9M | — | $1.81 | — | $356.8M | $256.1M | — |
| FY 2017 | $1,081.5M | +5.4% | $963.1M | $201.8M | +8.6% | $1.95 | +7.7% | $371.1M | $271.4M | +6.0% |
| FY 2018 | $1,171.9M | +8.4% | $1,043.7M | $122.2M | -39.4% | $1.14 | -41.5% | $352.2M | $279.4M | +2.9% |
| FY 2019 | $1,241.6M | +5.9% | $1,080.8M | $255.2M | +108.7% | $2.44 | +114.0% | $327.7M | $231.4M | -17.2% |
| FY 2020 | $1,161.8M | -6.4% | $1,015.3M | $231.4M | -9.3% | $2.25 | -7.8% | $343.8M | $277.5M | +19.9% |
| FY 2021 | $1,281.3M | +10.3% | $1,151.2M | $310.2M | +34.1% | $2.97 | +32.0% | $447.8M | $393.3M | +41.7% |
| FY 2022 | $1,253.8M | -2.1% | $1,112.4M | $184.1M | -40.7% | $1.81 | -39.1% | $318.6M | $270.6M | -31.2% |
| FY 2023 | $1,299.7M | +3.7% | $1,147.2M | $200.7M | +9.0% | $2.05 | +13.3% | $367.1M | $336.7M | +24.4% |
| FY 2024 | $1,273.7M | -2.0% | $1,133.2M | $261.8M | +30.5% | $2.69 | +31.2% | $327.3M | $297.2M | -11.7% |
| FY 2025 | $1,349.1M | +5.9% | $1,189.0M | $255.0M | -2.6% | $2.62 | -2.6% | $472.2M | $435.9M | +46.6% |
Valuation
Market Price
$62.36
Market Cap
$5.90B
Enterprise Value
N/A
P/E Ratio
23.80
P/B Ratio
2.25
FCF Yield
7.39%
Dividend Yield
2.12%
Shares Outstanding
Profitability & Margins
Gross Margin
88.13%
Operating Margin
19.64%
Net Margin
18.90%
Return on Equity (ROE)
9.72%
Return on Assets (ROA)
491.62%
Asset Turnover
26.01x
Revenue 3-Yr CAGR
2.47%
Financial Health & Liquidity
Current Ratio
0.14
Cash Ratio
1.90
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$701.89M
Total Debt
N/A
Book Value / Share
$27.72
Cash Flow Efficiency
Operating Cash Flow
$472.20M
Capital Expenditures (CapEx)
$36.35M
Free Cash Flow
$435.85M
OCF / Revenue
35.00%
FCF / Revenue
32.31%
FCF 3-Yr CAGR
17.21%
Per Share Metrics
EPS (Diluted)
$2.62
EPS (Basic)
$2.66
Dividends / Share
$1.32
Book Value / Share
$27.72
EPS YoY Growth
-2.60%
Balance Sheet (FY 2025)
Total Assets
$51.87M
Total Liabilities
$369.26M
Stockholders' Equity
$2.62B
Current Assets
$51.87M
Current Liabilities
$369.26M